Merck partners with King’s College London to develop painkillers

11-03-2019

Merck partners with King’s College London to develop painkillers

Katherine Welles / Shutterstock.com

King’s College London (KCL) has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.


Merck & Co, King's College London, licensing and collaboration agreement, Wellcome Trust, chronic pain

More on this story

Merck signs DNA licensing deal with Vertex
28-01-2019

LSIPR